Details of the Drug Formulations

General Information of Drug (ID: DM5FLTY)

• Drug Name: Risedronate Drug Info
• Synonyms: Risedronic acid; 105462-24-6; Actonel; Atelvia; Acido risedronico; Acidum risedronicum; Benet; Risedronic acid [INN:BAN]; Acidum risedronicum [INN-Latin]; Acido risedronico [INN-Spanish]; Acide risedronique [INN-French]; Risedronic acid monohydrate; NE-58095; UNII-KM2Z91756Z; C7H11NO7P2; NE 58019; HSDB 7326; [1-hydroxy-1-phosphono-2-(pyridin-3-yl)ethyl]phosphonic acid; (1-hydroxy-1-phosphono-2-pyridin-3-yl-ethyl)phosphonic acid; Risedronic acid (Actonel); CHEMBL923; CHEBI:8869; Phosphonic acid,; Benet; RIS; Ridron; Acide risedronique; Bisphosphonate 1; Actonel (TN); Ridron (TN); Risedronic acid (INN); (1-Hydroxy-2-(3-pyridyl)ethylidene)diphosphonic acid; (1-hydroxy-1-phosphono-2-pyridin-3-ylethyl)phosphonic acid; (1-hydroxy-2-pyridin-3-ylethane-1,1-diyl)bis(phosphonic acid); 1-HYDROXY-2-(3-PYRIDINYL)ETHYLIDENE BIS-PHOSPHONIC ACID

Indication

Disease Entry	ICD 11	Status	REF
Bone Paget disease		Approved	[1]
Osteoporosis	FB83.0	Approved	[1]
Paget's disease	FB85	Approved	[2]

• Therapeutic Class: Bone Density Conservation Agents
• Cross-matching ID:
  PubChem CID: 5245
  ChEBI ID: CHEBI:8869
  CAS Number: 105462-24-6
  TTD ID: D0PA5S
  ACDINA ID: D00598

Full List of Drug Formulations Containing This Drug

Risedronic acid 35 mg tablet

Company	Formulation ID	FDA Description
Teva Pharmaceuticals	F19028	Lactose monohydrate; Sodium stearyl fumarate; Fd&c yellow no. 6; Magnesium stearate; Ferric oxide red; Ferric oxide yellow; Titanium dioxide; Polyethylene glycol 400; Polysorbate 80; Silicon dioxide; Hypromellose 2910 (3 mpa.s); Hypromellose 2910 (5 mpa.s); Starch, corn
Apotex	F19027	Anhydrous lactose; Magnesium stearate; Ferric oxide red; Ferric oxide yellow; Titanium dioxide; Silicon dioxide; Crospovidone (15 mpa.s at 5%); Hydroxypropyl cellulose (type h); Hypromelloses; Polyethylene glycol 8000

Risedronic acid 5 mg tablet

Company	Formulation ID	FDA Description
Teva Pharmaceuticals	F19036	Lactose monohydrate; D&c yellow no. 10; Sodium stearyl fumarate; Magnesium stearate; Ferric oxide yellow; Titanium dioxide; Polyethylene glycol 400; Polysorbate 80; Silicon dioxide; Hypromellose 2910 (3 mpa.s); Hypromellose 2910 (5 mpa.s); Starch, corn
Mylan Pharamceuticals	F19035	Fd&c blue no. 2; Fd&c yellow no. 6; Magnesium stearate; Mannitol; Titanium dioxide; Triacetin; Silicon dioxide; Crospovidone (15 mpa.s at 5%); Hypromellose, unspecified; Microcrystalline cellulose; Polydextrose; Polyethylene glycol, unspecified
Sun Pharmaceutical Industries	F19034	Magnesium stearate; Mannitol; Ferric oxide yellow; Talc; Titanium dioxide; Polyvinyl alcohol; Silicon dioxide; Cellulose, microcrystalline; Croscarmellose; Polyethylene glycols; Starch, corn
Warner Chilcott Pharmaceuticals	F19030	Lactose monohydrate; Magnesium stearate; Ferric oxide yellow; Titanium dioxide; Crospovidone; Hypromellose; Silicon dioxide; Cellulose, microcrystalline; Hydroxypropyl cellulose; Polyethylene glycol
Aurobindo Pharma	F19032	Lactose monohydrate; Magnesium stearate; Ferric oxide yellow; Titanium dioxide; Crospovidone; Polyethylene glycol 400; Silicon dioxide; Cellulose, microcrystalline; Hydroxypropyl cellulose (type h); Hypromellose 2910 (5 mpa.s)
Macleods Pharmaceuticals	F19029	Anhydrous lactose; Magnesium stearate; Ferric oxide yellow; Titanium dioxide; Crospovidone; Silicon dioxide; Cellulose, microcrystalline; Hydroxypropyl cellulose (type h); Hypromelloses; Polyethylene glycols
Physicians Total Care	F19031	Lactose monohydrate; Magnesium stearate; Ferric oxide yellow; Titanium dioxide; Crospovidone; Silicon dioxide; Cellulose, microcrystalline; Hydroxypropyl cellulose; Hypromelloses; Polyethylene glycol
Actavis Pharma; Allergan	F19033	Lactose monohydrate; Magnesium stearate; Ferric oxide yellow; Titanium dioxide; Crospovidone; Silicon dioxide; Cellulose, microcrystalline; Hydroxypropyl cellulose (type h); Hypromelloses; Polyethylene glycols

Risedronic acid 150 mg tablet

Company	Formulation ID	FDA Description
Sun Pharmaceutical Industries	F19016	Fd&c blue no. 2; Magnesium stearate; Mannitol; Talc; Titanium dioxide; Polyvinyl alcohol; Silicon dioxide; Cellulose, microcrystalline; Croscarmellose; Polyethylene glycols; Starch, corn
Mylan Pharamceuticals	F19017	Fd&c blue no. 2; Fd&c yellow no. 6; Magnesium stearate; Mannitol; Titanium dioxide; Silicon dioxide; Crospovidone (15 mpa.s at 5%); Hypromellose, unspecified; Microcrystalline cellulose; Polydextrose; Polyethylene glycol, unspecified
Warner Chilcott Pharmaceuticals	F19014	Fd&c blue no. 2; Magnesium stearate; Titanium dioxide; Crospovidone; Hypromellose; Silicon dioxide; Aluminum oxide; Cellulose, microcrystalline; Hydroxypropyl cellulose; Polyethylene glycol
Aurobindo Pharma	F19018	Fd&c blue no. 2; Magnesium stearate; Titanium dioxide; Crospovidone; Polyethylene glycol 400; Silicon dioxide; Cellulose, microcrystalline; Hydroxypropyl cellulose (type h); Hypromellose 2910 (6 mpa.s); Polyethylene glycol 8000
Teva Pharmaceuticals	F19019	Lactose monohydrate; Sodium stearyl fumarate; Magnesium stearate; Talc; Titanium dioxide; Polyethylene glycol 3350; Silicon dioxide; Polyvinyl alcohol, unspecified; Starch, corn
Actavis Pharma; Allergan	F19013	Fd&c blue no. 2; Magnesium stearate; Titanium dioxide; Crospovidone; Silicon dioxide; Cellulose, microcrystalline; Hydroxypropyl cellulose (type h); Hypromelloses; Polyethylene glycols
Physicians Total Care	F19015	Fd&c blue no. 2; Magnesium stearate; Titanium dioxide; Crospovidone; Silicon dioxide; Aluminum oxide; Cellulose, microcrystalline; Hydroxypropyl cellulose; Hypromelloses; Polyethylene glycol
Apotex	F19012	Anhydrous lactose; Fd&c blue no. 2; Magnesium stearate; Titanium dioxide; Sodium phosphate, monobasic, monohydrate; Silicon dioxide; Crospovidone (15 mpa.s at 5%); Hydroxypropyl cellulose (type h); Hypromelloses; Polyethylene glycol 8000; Sodium phosphate, dibasic

Risedronic acid 30 mg tablet

Company	Formulation ID	FDA Description
Teva Pharmaceuticals	F19026	Lactose monohydrate; Sodium stearyl fumarate; Magnesium stearate; Titanium dioxide; Polyethylene glycol 400; Polysorbate 80; Silicon dioxide; Hypromellose 2910 (3 mpa.s); Hypromellose 2910 (5 mpa.s); Starch, corn
Sun Pharmaceutical Industries	F19024	Magnesium stearate; Mannitol; Talc; Titanium dioxide; Polyvinyl alcohol; Silicon dioxide; Cellulose, microcrystalline; Croscarmellose; Polyethylene glycols; Starch, corn
Mylan Pharamceuticals	F19025	Magnesium stearate; Mannitol; Titanium dioxide; Triacetin; Silicon dioxide; Crospovidone (15 mpa.s at 5%); Hypromellose, unspecified; Microcrystalline cellulose; Polydextrose; Polyethylene glycol, unspecified
Warner Chilcott Pharmaceuticals	F19023	Lactose monohydrate; Magnesium stearate; Titanium dioxide; Crospovidone; Hypromellose; Silicon dioxide; Cellulose, microcrystalline; Hydroxypropyl cellulose; Polyethylene glycol
Macleods Pharmaceuticals	F19020	Anhydrous lactose; Magnesium stearate; Titanium dioxide; Crospovidone; Silicon dioxide; Cellulose, microcrystalline; Hydroxypropyl cellulose (type h); Hypromelloses; Polyethylene glycols
Aurobindo Pharma	F19021	Lactose monohydrate; Magnesium stearate; Titanium dioxide; Crospovidone; Polyethylene glycol 400; Cellulose, microcrystalline; Hydroxypropyl cellulose (type h); Hypromellose 2910 (5 mpa.s)
Actavis Pharma; Allergan	F19022	Lactose monohydrate; Magnesium stearate; Titanium dioxide; Crospovidone; Silicon dioxide; Cellulose, microcrystalline; Hydroxypropyl cellulose (type h); Hypromelloses; Polyethylene glycols

Risedronic acid 75 mg tablet

Company	Formulation ID	FDA Description
Sun Pharmaceutical Industries	F19039	Magnesium stearate; Mannitol; Ferric oxide red; Talc; Titanium dioxide; Polyvinyl alcohol; Silicon dioxide; Cellulose, microcrystalline; Croscarmellose; Polyethylene glycols; Starch, corn
Actavis Pharma	F19038	Magnesium stearate; Ferric oxide red; Titanium dioxide; Crospovidone; Silicon dioxide; Cellulose, microcrystalline; Hydroxypropyl cellulose (type h); Hypromelloses; Polyethylene glycols
Apotex	F19037	Anhydrous lactose; Magnesium stearate; Ferric oxide red; Titanium dioxide; Silicon dioxide; Crospovidone (15 mpa.s at 5%); Hydroxypropyl cellulose (type h); Hypromelloses; Polyethylene glycol 8000

References

• [1] Risedronate FDA Label
• [2] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3176).